$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
An analysis of whether Bestifan (Viliru) can be used in combination with other anti-tumor drugs
2026-02-01 22:25:32
Check Details
Analysis of the main indications and clinical users of dabrafenib (Tefila)
2026-02-01 22:25:32
Check Details
Is there a domestic version of Axitinib and the latest news on domestic research and development progress?
2026-02-01 22:25:32
Check Details
How to adjust the dosage of Trametinib (Megenin) and reference for patients with different weights
2026-02-01 22:25:32
Check Details
What is avatrombopag (Su Kexin) and its treatment principle explanation
2026-02-01 22:25:32
Check Details
Is there any generic version of Gilteritinib and its market price comparison?
2026-02-01 22:25:32
Check Details
How many years should pirfenidone (Isri) be used to treat pulmonary fibrosis and its course of treatment should be evaluated
2026-02-01 22:25:32
Check Details
Differences and medication options between canafenib/encofenib (bitavir) and vemurafenib
2026-02-01 22:25:32
Check Details
Which company produces Imatinib and an introduction to drug quality assurance
2026-02-01 22:25:32
Check Details
Ruxolitinib Cream (Opzelura) Manufacturer and Drug Quality Assurance Information
2026-02-01 22:25:32
Check Details
Analysis of how many months and treatment courses it usually takes to cure hepatitis C with Epclusa
2026-02-01 22:25:32
Check Details
Introduction to the price and purchase channels of foreign generic drugs of Sunitinib
2026-02-01 22:25:32
Check Details
1
2
...
2052
2053
2054
2055
2056
2057
2058
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
2
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
3
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
4
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
5
ROS and Cancer: The Potential of Natural Antioxidants
6
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
7
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
8
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
9
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
10
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
11
From Causes to Treatments—Exploring Medical Breakthroughs
12
IRX4 Transcription Factor: New Research Insights on Colorectal Cancer Treatment Targets